Upstate Medical University in Syracuse, NY, the Technion-Israel Institute of Technology in Haifa, and the National Cheng Kung University (NCKU) in Tainan City, Taiwan, are creating the International Institute of Biomedical Sciences and Technology. Ultimately, the institute is expected to grow beyond these three initial founding institutions to incorporate other universities and medical schools worldwide.
The aim for the institute is to facilitate collaborative research and accelerate the development of novel bioengineering, diagnostic, and biomedical products. The areas highlighted for research, which are still being discussed, are expected to include cancer, diabetes, infectious and cardiovascular diseases, as well as disorders of the nervous system.
“The creation of this cross-continent research institute immediately brings all three campuses together in the name of scientific discovery,” remarks Upstate’s Steven Goodman, Ph.D., vp for research and dean of the College of Graduate Studies. Dr. Goodman will serve as the institute’s executive director and be responsible for the daily activities.
“The purpose of the institute is to bring together top scientists in the biological, physical, mathematical, engineering, and computer sciences to form interdisciplinary teams aimed at solving essential issues in human health and society.”
Upstate’s annual research expenditures approach $40 million, according to the University, with activity in nervous system disorders, diabetes, metabolic disorders, cardiovascular disease, cancer, and infectious diseases.
Technion-Israel Institute of Technology is reportedly Israel’s oldest university and acts as a center for scientific and technological research. It has a medical school and couples research in nanotechnology, fiber optics, and other areas with work in the life sciences and medicine.
NCKU is approximately 155.35 miles (250 km) south of Taipei. It has evolved from its engineering genesis to become a research center and university for the Asia Pacific region.